BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Capricorn Pharma Inc. and TEVA Pharmaceuticals USA (TEVA) Enter Into Agreement


8/5/2008 6:30:31 AM

FREDERICK, Md.--(BUSINESS WIRE)--S. Rao Cherukuri---Founder, President and Chief Executive Officer of Capricorn Pharma Inc., announced today that his company has an agreement with Teva Pharmaceuticals USA to develop products using Capricorn’s proprietary KORKOAT technology platform.

KORKOAT beads accommodate high drug loads; modified drug release can be achieved by incorporating release-modifying agents inside the bead, in the coating, or in both.

“We are honored and pleased to have this agreement with Teva,” Mr. Cherukuri said. “We are proud of our technologies, which offer flexible solutions to difficult formulation challenges. We believe this agreement further validates our commercialized oral drug delivery technology platforms and Capricorn’s proprietary encapsulation processes.”

Terms of the agreement were not disclosed.

About Capricorn Pharma Inc.

Frederick, Maryland-based Capricorn Pharma is a specialty oral drug delivery systems company that develops, commercializes, and manufactures pharmaceutical products. The company has five commercialized oral drug delivery technology platforms and seven commercialized encapsulation processes.

Contact:

Capricorn Pharma Inc. Nivaran Kapur (T)301.696.1452 nivarank@capricornpharma.com www.capricornpharma.com

Source: Capricorn Pharma Inc.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES